Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Atara Biotherapeutics (ATRA) Inventory Average (2023 - 2024)

Atara Biotherapeutics filings provide 2 years of Inventory Average readings, the most recent being $12.3 million for Q4 2024.

  • On a quarterly basis, Inventory Average rose 51.16% to $12.3 million in Q4 2024 year-over-year; TTM through Dec 2024 was $12.3 million, a 51.16% increase, with the full-year FY2024 number at $10.2 million, up 80.31% from a year prior.
  • Inventory Average hit $12.3 million in Q4 2024 for Atara Biotherapeutics, down from $16.4 million in the prior quarter.
  • In the past five years, Inventory Average ranged from a high of $17.4 million in Q2 2024 to a low of $3.5 million in Q1 2023.